Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Institute of CNS Pharmacology
Alternate name:
CNS薬理研究所
ROR:
01bb2pq32
OpenAlex ID:
I4405283266
Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia in Japan: A 6‐week, randomized, double‐blind, placebo‐controlled study
2018
·
Jun Ishigooka
, Shuichi Iwashita
, et al.
·
Psychiatry and Clinical Neurosciences
·
65
PDF
Double‐blind , placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression
2020
·
Tadafumi Kato
, Jun Ishigooka
, et al.
·
Psychiatry and Clinical Neurosciences
·
52
PDF
The effect of short or long sleep duration on quality of life and depression: an internet-based survey in Japan
2020
·
Kentaro Matsui
, Kenichi Kuriyama
, et al.
·
Sleep Medicine
·
46
Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study
2019
·
Nakao Iwata
, Jun Ishigooka
, et al.
·
Schizophrenia Research
·
45
PDF
Pharmacokinetics and Safety of Brexpiprazole Following Multiple‐Dose Administration to Japanese Patients With Schizophrenia
2017
·
Jun Ishigooka
, Shuichi Iwashita
, et al.
·
The Journal of Clinical Pharmacology
·
40
PDF
Lurasidone in the treatment of schizophrenia: Results of a double‐blind, placebo‐controlled trial in Asian patients
2019
·
Teruhiko Higuchi
, Jun Ishigooka
, et al.
·
Asia-Pacific Psychiatry
·
39
Promoter Activity-Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients With Schizophrenia
2020
·
Tempei Ikegame
, Miki Bundo
, et al.
·
Schizophrenia Bulletin
·
37
PDF
Long‐term safety and effectiveness of brexpiprazole in Japanese patients with schizophrenia: A 52‐week, open‐label study
2018
·
Jun Ishigooka
, Shuichi Iwashita
, et al.
·
Psychiatry and Clinical Neurosciences
·
36
PDF
Paroxetine in the treatment of obsessive‐compulsive disorder: randomized, double‐blind, placebo‐controlled study in Japanese patients
2004
·
KUNITOSHI KAMIJIMA
, MITSUKUNI MURASAKI
, et al.
·
Psychiatry and Clinical Neurosciences
·
35
PDF
Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia
2011
·
Masako Kohsaka
, Takashi Kanemura
, et al.
·
Expert Review of Neurotherapeutics
·
34
Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression
2018
·
Mitsukuni Murasaki
, Tsukasa Koyama
, et al.
·
Psychopharmacology
·
32
PDF
Analysis of Clozapine Use and Safety by Using Comprehensive National Data From the Japanese Clozapine Patient Monitoring Service
2018
·
Ken Inada
, Hidehiro Oshibuchi
, et al.
·
Journal of Clinical Psychopharmacology
·
28
Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6‐week, randomized, double‐blind, placebo‐controlled study
2021
·
Masaomi Iyo
, Jun Ishigooka
, et al.
·
Psychiatry and Clinical Neurosciences
·
26
Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8‐week, double‐blind, multicenter, randomized controlled study
2019
·
Philip D. Harvey
, Hiroshi Nakamura
, et al.
·
Neuropsychopharmacology Reports
·
25
PDF
Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study
2019
·
Nakao Iwata
, Jun Ishigooka
, et al.
·
CNS Drugs
·
24
PDF
Randomized, double‐blind, placebo, and risperidone‐controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6‐week trial
2019
·
Teruhiko Higuchi
, Masaomi Iyo
, et al.
·
Asia-Pacific Psychiatry
·
24
A rare genetic variant in the cleavage site of prepro-orexin is associated with idiopathic hypersomnia
2022
·
Taku Miyagawa
, Susumu Tanaka
, et al.
·
npj Genomic Medicine
·
22
PDF
Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
2022
·
Takuya Saito
, Saori Sugimoto
, et al.
·
Journal of Child and Adolescent Psychopharmacology
·
20
Clozapine‐induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine
2020
·
Kentaro Matsui
, Mikiko Ishibashi
, et al.
·
Human Psychopharmacology Clinical and Experimental
·
14
Effect of Yokukansan for the Treatment of Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Retrospective Analysis of Consecutive Patients
2019
·
Kentaro Matsui
, Taeko Sasai-Sakuma
, et al.
·
Journal of Clinical Sleep Medicine
·
14
Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study
2021
·
Takuya Saito
, Yohei Hyodo
, et al.
·
Journal of Child and Adolescent Psychopharmacology
·
13
Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
2021
·
Mitsukuni Murasaki
, Yoshifumi Inoue
, et al.
·
Annals of General Psychiatry
·
13
PDF
Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
2021
·
Masaomi Iyo
, Jun Ishigooka
, et al.
·
Neuropsychiatric Disease and Treatment
·
12
PDF
Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study
2021
·
Jun Ishigooka
, Ken Inada
, et al.
·
Human Psychopharmacology Clinical and Experimental
·
12
PDF
Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study
2020
·
Jun Ishigooka
, Tadafumi Kato
, et al.
·
Journal of Affective Disorders
·
11
Show more works
View as search
Works count:
52
Citation count:
812
Year
Topic
Type
